Sarah Linklater is Editor-in-Chief of The Lancet Diabetes & Endocrinology. Sarah obtained a PhD in Experimental Medicine after studying autoimmunity and human regulatory T cells at the University of British Columbia in Vancouver, Canada, and at the Hospital San Raffaele in Milan, Italy. In 2008, Sarah moved to the UK to pursue a career in scientific publishing, first as an editor with Nature Publishing Group in London and later with The Company of Biologists in Cambridge. She joined The Lancet group in early 2013 to help launch The Lancet Diabetes & Endocrinology, which published its first issue in September, 2013. She is based in London, UK.